NCT05934149 Lupus Landmark Study: A Prospective Registry and Biorepository
| NCT ID | NCT05934149 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lupus Research Alliance |
| Condition | Systemic Lupus Erythematosus (SLE) |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,500 participants |
| Start Date | 2023-06-28 |
| Primary Completion | 2035-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,500 participants in total. It began in 2023-06-28 with a primary completion date of 2035-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the registry and biorepository is to provide a mechanism to store clinical data, linked biospecimens and molecular data to support the conduct of future research on Systemic Lupus Erythematosus (SLE), including Lupus Nephritis (LN).
Eligibility Criteria
Inclusion Criteria: * Able to understand and comply with study procedures and voluntarily sign a written informed consent document * Age 18 years or older at the time of enrollment * Fulfill criteria for SLE based on one or more of the following classifications systems: Systemic Lupus Erythematosus International Collaborating Clinic (SLICC) 2012 criteria; European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) 2019 criteria; 1997 revised ACR criteria; or Lupus is present per clinical assessment. Exclusion Criteria: * Not able to obtain consent * Not able to meet protocol visit requirements * Pregnant at the time of enrollment
Contact & Investigator
Sam Lim, MD, MPH
PRINCIPAL INVESTIGATOR
Emory University
Frequently Asked Questions
Who can join the NCT05934149 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 110 Years, studying Systemic Lupus Erythematosus (SLE). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05934149 currently recruiting?
Yes, NCT05934149 is actively recruiting participants. Contact the research team at lupusnexus@lupusresearch.org for enrollment information.
Where is the NCT05934149 trial being conducted?
This trial is being conducted at Birmingham, United States, Tucson, United States, Beverly Hills, United States, Los Angeles, United States and 11 additional locations.
Who is sponsoring the NCT05934149 clinical trial?
NCT05934149 is sponsored by Lupus Research Alliance. The principal investigator is Sam Lim, MD, MPH at Emory University. The trial plans to enroll 3,500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.